Chloe Douglas-Crampton
Plus aucun poste en cours
Health Technology
Historique de carrière de Chloe Douglas-Crampton
Anciens postes connus de Chloe Douglas-Crampton
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
| TRILLIUM THERAPEUTICS | Public Communications Contact | 01/11/2004 | - |
| Secrétaire Général | 19/10/2009 | - |
Statistiques
Internationale
| Canada | 2 |
Opérationnelle
| Public Communications Contact | 1 |
| Corporate Secretary | 1 |
Sectorielle
| Health Technology | 2 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
| Entreprise privées | 1 |
|---|---|
Trillium Therapeutics ULC
 Trillium Therapeutics ULC BiotechnologyHealth Technology Trillium Therapeutics, Inc. is a clinical stage immuno-oncology company, which engages in the research and development of therapies for the treatment of cancer. It offers clinical programs, TTI-621 and TTI-622, target CD47, a signal that cancer cells frequently use to evade the immune system. The company was founded on March 31, 2004 and is headquartered in Mississauga, Canada. | Health Technology |
- Bourse
- Insiders
- Chloe Douglas-Crampton
- Expérience
